Investigating the dual nature of Clostridium botulinum: pathogenic mechanisms and therapeutic potentials
infezioni in medicina · 01.03.2026 · 34 (1)
DOI: 10.53854/liim-3401-1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift infezioni in medicina, online erschienen am 01.03.2026. Verfasst von Kosar Soleymanpour und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Molecular Biology, Ta.C., Islamic Azad University, Tabriz, Iran. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cellular and Molecular Biology, Ta.C., Islamic Azad University, Tabriz, Iran.
- Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran.
- Research Laboratory of Microbiology and Virology, Baku State University, Baku, Republic of Azerbaijan.
- Biotechnology Research center, Faculty of Para Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
- Drug Applied Research center, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Zitieren
APA
Soleymanpour, K., Zeinalzadeh, E., Ganbarov, K., Asgharzadeh, M., & Kafil, H. S. (2026). Investigating the dual nature of Clostridium botulinum: pathogenic mechanisms and therapeutic potentials. infezioni in medicina, 34(1). https://doi.org/10.53854/liim-3401-1
Vancouver
Soleymanpour K, Zeinalzadeh E, Ganbarov K, Asgharzadeh M, Kafil HS. Investigating the dual nature of Clostridium botulinum: pathogenic mechanisms and therapeutic potentials. infezioni in medicina. 2026;34(1). doi:10.53854/liim-3401-1
BibTeX
@article{Soleymanpour2026,
author = {Soleymanpour, Kosar and Zeinalzadeh, Elham and Ganbarov, Khudaverdi and Asgharzadeh, Mohammad and Kafil, Hossein Samadi},
title = {Investigating the dual nature of Clostridium botulinum: pathogenic mechanisms and therapeutic potentials},
journal = {infezioni in medicina},
year = {2026},
volume = {34},
number = {1},
doi = {10.53854/liim-3401-1}
}
EUVIMED